Osteoblasts and Bone Formation

Advances in Organ Biology

Volumn 5, Issue C, 1998, Pages 445-473

  Marie, Pierre J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042605320     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60130-5     Document Type: Article

References (188)

1. Adams J.C., and Watt F.M. Regulation of development and differentiation by the extracellular matrix. Development 117 (1993) 1183-1198
2. Agarwal M.K., Mirshahi F., Mirshahi M., Bracq S., Chentoufi J., Hott M., Jullienne A., and Marie P.J. Evidence for receptor-mediated mineralocorticoid action in rat osteoblastic cells. Am. J. Physiol. (1996) In press.
3. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., and Karaplis A.C. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 126 (1994) 1611-1623
4. Andrianarivo A.G., Robinson J.A., Mann K.G., and Tracy R.P. Growth on type-1 collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell. Physiol. 153 (1992) 256-265
5. Angel P., and Karin M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072 (1991) 129-157
6. Aubin J.E., and Liu F. The osteoblast lineage. In: Bilezikia, Raisz, and Rodan (Eds). Principles of Bone Biology (1996), Academic Press, New York 51-67
7. Bab I., and Einhorn T.A. Regulatory role of osteogenic growth polypeptides in bone formation and hemopoiesis. Crit. Rev. Eukaryot Gene Expression 3 (1993) 31-46
8. Balmain N., Von Eichel B., Toury R., Belquasmi F., Hauchecorne M., Klaus G., Mehls O., and Ritz E. Calbindin-D28Kand -D9K and l,25(OH)2 vitamin D3 receptor immunolocalization and mineralization induction in long term primary cultures of rat epiphyseal chondrocytes. Bone 17 (1995) 37-45
9. Bellows C.G., Aubin J.E., and Heersche J.N.M. Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner. 14 (1991) 27-40
10. Bellows C.G., Heersche J.N.M., and Aubin J.E. Inorganic phosphate added exogenously or released from β-glycerophosphate initiates mineralization of osteoid nodules in vitro. Bone and Mineral 17 (1992) 15-29
11. Beresford J.N. Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. 240 (1989) 270-280
12. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., and Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102 (1992) 341-351
13. Bodine P.V.N., Riggs L.B., and Spelsberg T.C. Regulation of c-fos expression and TGF-β production by gonadal and adrenal androgens in normal human osteoblastic cells. J. Steroid Biochem. Molec. Biol. 52 (1995) 149-155
14. Bianco P., Fishert L.W., and Young M.F. Expression of bone sialoprotein in human developing bone as revealed by immunostaining and in situ hybridization. J. Bone Miner. Res. 4 (1989) 246-249
15. Bonewald L.F., and Dallas S.L. Role of active and latent transforming growth factor in bone formation. J. Cell. Biochem. 55 (1994) 350-360
16. Bruder S., and Caplan A. A monoclonal antibody against the surface of osteoblasts recognises alkaline phosphatase isoenzymes in bone, liver, kidney, and intestine. Bone 11 (1989) 133-139
17. Burridge K., Petch L.A., and Romer L.H. Signals from focal adhesions. Current Opinion Cell Biol. 2 (1992) 537-539
18. Canalis E., McCarthy T.L., and Centrella M. Growth factors and cytokines in bone cell metabolism. Annu. Rev. Med. 42 (1991) 17-24
19. Candeliere G.A., Glorieux F.H., Prud'homme J., and Arnaud R.St. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N. Eng. J. Med. 332 (1995) 1546-1578
20. Caversazio J., Seltz T., and Bonjour J.-P. Characteristics of phosphate transport in osteoblastlike cells. Cacif. Tissue Int. 43 (1988) 83-87
21. Centrella M., McCarthy T., and Canalis E. Current concepts review: Transforming growth factor β and remodeling of bone. J. Bone Joint. Surg. 73A (1991) 1418-1428
22. Centrella M., Horowitz M.C., Wozney J.M., and McCarthy T.L. Transforming growth factor-β gene family members and bone. Endocrine Rev. 15 (1994) 27-39
23. Chaudhary L., Spelsberg T.C., and Riggs B.L. Production of various cytokines by normal human osteoblasflike cells in response to interleukin-1β and tumor necrosis factor-α: Lack of regulation by 17β-estradiol. Endocrinology 130 (1992) 2528-2534
24. Chen D., Ji X., Harris M.A., Feng J.K., Karsenty G., Celeste A.J., Rosen V., Mundy G.R., and Harris S.E. Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J. Cell Biol. 142 1 (1998) 295-305
25. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., and Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 (1994) 277-286
26. Chentoufi J., Hott M., Lamblin D., Buc-Caron M.H., Marie P.J., and Kellermann O. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 53 (1993) 181-189
27. Chentoufi J., and Marie P.J. Interactions between retinoic acid and 1,25(OH)2D in mouse immortalized osteoblastic CI cells. Am. J. Physiol. 266 (1994) 1247-1256 Cell Physiol. 35
28. Civitelli R., Beyer E.C., Warlow P.M., Robertson A.J., Geist S.T., and Steinberg T.H. Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J. Clin. Invest. 91 (1993) 1888-1896
29. Closs E.I., Murray B.A., Schmidt J., Schon A., Erfle V., and Strauss P.G. C-fos expression precedes osteogenic differentiation of cartilage cells in vitro. J. Cell Biol. 111 (1990) 1313-1323
30. Collin P., Nefussi J.R., Wetterwald A., Nicolas V., Boy-Lefevre M.L., Fleisch H., and Forest N. Expression of collagen, osteocalcin, and bone alkaline phosphatase in a mineralizing rat osteoblastic cell culture. Calcif. Tissue Int. 50 (1992) 175-183
31. Damsky C.H., and Werb Z. Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information. Curr. Opin. Cell Biol. 4 (1992) 772-781
32. Debiais F., Hott M., Graulet A.M., and Marie P.J. Fibroblast growth factor-2 differently affects human neonatal calvaria osteoblastic cells depending on the stage of cell differentiation. J. Bone Miner. Res. 13 4 (1998) 645-654
33. De Pollak C., Renier D., Hott M., and Marie P.J. Increased bone formation and osteoblastic cell phenotype in premature cranial ossification (craniosynostosis. J. Bone Min. Res. 11 (1996) 401-407
34. De Pollak C., Arnaud E., Renier D., and Marie P.J. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J. Cell. Biochem. 64 (1997) 128-139
35. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., Smith E., Bonadio J., Goldstein S., Gundberg C., Bradley A., and Karsenty G. Increased bone formation in osteocalcin-deficient mice. Nature 382 (1996) 448-452
36. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbf1: A transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
37. Erlebacher A., Filvaroff E.H., Gitelman S.E., and Derynck R. Toward a molecular understanding of skeletal development. Cell 80 (1995) 371-378
38. Emst M., Heath J.K., Schmid C., Froesch R.E., and Rodan G.A. Evidence for a direct effect of estrogen on bone cells in vitro. J. Steroid Biochem. 34 (1989) 279-284
39. Ev ans C.E., Galasko C.S.D., and Ward C. Effect of donor age on the growth in vitro of cells obtained from human trabecular bone. J. Orthopaedic Res. 8 (1990) 234-237
40. Falla N., van Vlasselaer P., Bierkens J., Borremans B., Schoeters G., and van Gorp U. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood 82 (1993) 3580-3591
41. Fedarko N.S., Vetter U.K., Weibstein S., and Gehron-Robey P. Age-related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells. J. Cell. Physiol. 151 (1992) 215-227
42. Franceschi R.T., and Iyer B.S. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J. Bone Min. Res. 7 (1992) 235-240
43. Fromigué O., Marie P.J., and Lomri A. Differential effects of transforming growth factor-β, 1,25-dihydroxyvitamin D, and dexamethasone on human bone marrow stromal cells. Cytokine 9 8 (1997) 613-623
44. Fromigué O., Marie P.J., and Lomri A. Bone morphogenetic protein-2 and transforming growth factor β2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J. Cell Biochem. 68 (1998) 411-426
45. Garba M.T., and Marie P.J. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse. Calcif. Tissue Int. 38 (1986) 296-302
46. Gehron-Robey P. The biochemistry of bone. Endocrinol. Metab. Clinics of North America 18 (1989) 859-902
47. Ghosh-Choudhury N., Harris M.A., Feng J.Q., Mundy G.R., and Harris S.E. Expression of the BMP2 gene during bone cell differentiation. Crit. Rev. Euk. Gene Exp. 4 (1994) 345-355
48. Glimcher M.J. Mechanism of calcification: Role of collagen fibrils and collagen-phosphoprotein complexes in vitro and in vivo. Anat. Rec. 224 (1989) 139-153
49. Godet D., and Marie P.J. Effects of the tripeptide glycyl-L-Histidyl-L-Lysine copper complex on osteoblastic cell spreading, attachment, and phenotype (1995). Cell. Mol. Biol. 41 (1995) 1081-1091
50. Goldring M.B., and Goldring S.R. Skeletal tissue response to cytokines. Clin Orthop 258 (1990) 245-275
51. In: Gowen M. (Ed). Cytokines and Bone Metabolism (1992), CRC Press, Ann Arbor, Michigan 1-417
52. Green J., Luong K.V.Q., Kleeman C.R., Ye L.-H., and Chaimovitz C. 1,25-dihydroxyvitamin D3 inhibits Na+-dependent phosphate transport in osteoblastic cells. Am. J. Physiol. 264 (1993) C287-C295 Cell Physiol. 33
53. Grigoriadis A.E., Schellander K., Wang Z.Q., and Wagner E.F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122 (1993) 685-701
54. Grigoriadis A.E., Heersche J.N.M., and Aubin J.E. Differentiation of muscle, fat, cartilageand bone progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J. Cell Biol. 106 (1988) 2139-2151
55. Grzesik W.J., and Gehron-Robey P. Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J. Bone Min Res. 9 (1994) 487-495
56. Halstead L.R., Scott M.J., Rifas L., and Avioli L.V. Characterization of osteoblastlike cells from normal adult rat femoral trabecular bone. Calcif. Tissue Int. 50 (1992) 93-95
57. Harada S.-I., Matsumoto T., and Ogata E. Role of ascorbic acid in the regulation of proliferation in osteoblastlike MC3T3-E1 cells. J. Bone Min. Res. 6 (1991) 903-908
58. Harada S., Nagy J.A., Sullivan K.A., Thomas K.A., Endo N., Rodan G.A., and Rodan S.B. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Invest. 93 (1994) 2490-2496
59. Harris S.E., Bonewald L.F., Harris M.A., Sabatini M., Dallas S., Feng J.Q., Ghosh-Choudhury N., Wozney J., and Mundy G.R. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type-I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9 (1994) 855-863
60. 3 in bone cells. Biochim. Biophys. Acta 1174 (1993) 11-16
61. Hodgkinson J.E., Davidson C.L., Beresford J., and Sharpe P.T. Expression of a human homeobox-containing gene is regulated by l,25(OH)2D3 in bone cells. Biochim. Biophys. Acta 1174 (1993) 11-16
62. Horowitz M.C., Coleman D.L., Hood P.M., Kupper T.S., and Jilka R.L. Parathyroid hormone and lipopolysaccharide induce murine osteoblastlike cells to secrete a cytokine indistinguishable from granulocyte-macrophage colony-stimulating factor. J. Clin. Invest. 83 (1989) 149-157
63. Hughes D.E., Salter D.M., Dedphar S., and Simpson R. Integrin expression in human bone. J. Bone Miner. Res. 8 (1993) 527-533
64. Ingber D. Integrins as mechanochemical transducers. Curr. Opin. Cell Biol. 3 (1991) 841-848
65. Jacenko O., Olsen B.R., and Warman M.L. Of mice and men: Heritable skeletal disorders. Am. J. Hum. Genet. 54 (1994) 163-168
66. Jackson M.E., Shalhoub V., Lian J.B., Stein G.S., and Marks S.C. Aberrant gene expression in cultured mamallian bone cells demonstrates an osteoblast defect in osteopetrosis. J. Cell. Biochem. 55 (1994) 366-372
67. Johnson R.S., Spiegelman B.M., and Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71 (1992) 577-586
68. Johnston R.L., and Tabin C.J. Molelcular models for vertebrate limb development. Cell 90 (1997) 979-990
69. Jones D.B., and Bingmann D. How do osteoblasts respond to mechanical stimulation?. Cells Materials 1 (1991) 329-340
70. Jones D.B., Nolte H., Scholbbers J.G., Turner E., and Veltel D. Biochemical signal transduction of mechanical strain in osteoblastlike cells. Biomaterials 12 (1991) 101-110
71. Kahn A., Gibbons R., Perkins S., and Gazit D. Age-related bone loss. A hypothesis and initial assessment in mice. Clin. Oth. Rel. Res. 313 (1995) 69-75
72. Kamalia N., McCulloch C.A.G., Tenenbaum H.C., and Limeback H. Dexamethasone recruitment of self-renewing osteoprogenitor cells in chick bone marrow stromal cell culture. Blood 79 (1992) 320-326
73. Kano J., Sugimoto T., Kanatani M., Kuroki Y., Tsukamoto T., Fukase M., and Chihara K. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic ostesarcoma cells: Its role in osteoblast proliferation and osteoclastlike cell formation. J. Cell. Physiol. 161 (1994) 358-366
74. Karaplis A.C. Gene targeting. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, New York 1189-1202
75. Kato H., Matsuo R., Komiyama O., Tanaka T., Inazu M., Kitagawa H., and Yoneda T. Decreased mitogenic and osteogenic responsiveness of calvarial osteoblasts isolated from aged rats to basic fibroblast growth factor. Geront. 41 (1995) 20-27
76. Kawaguchi H., Pilbeam C.C., Harrison J.R., and Raisz L.G. The role of prostaglandins in the regulation of bone metabolism. Clin. Oth. Rel. Res. 313 (1995) 36-46
77. Kasugai S., Todescan R., Nagata T., Yao K.L., Butler W.T., and Sodek J. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotype. J. Cell. Physiol. 147 (1991) 111-120
78. Keeting P.E., Rifas L., Harris S.A., Colvard D.S., Spelsberg T.C., Peck W.A., and Riggs B.L. Evidence of interleukin-1 production by cultured normal human osteoblastlike cells. J Bone Mineral Res. 6 (1991) 827-833
79. Keila S., Pitaru S., Grosskopf A., and Weinreb M. Bone marow from mechanically unloaded rat bones express reduced osteogenic capacity in vitro. J. Bone Miner. Res. 9 (1994) 321-327
80. Kellermann O., Buc-Caron M.H., Marie P.J., Lamblin D., and Jacob F. An immortalized osteogenic cell line derived from mouse teratocarcinoma is able to mineralize in vivo and in vitro. J. Cell Biol. 110 (1990) 123-132
81. Krieger N.S. Evidence for sodium-calcium exchange in rodent osteoblasts. Ann. NY. Acad. Sci. 639 (1991) 660-662
82. Krumlauf R. Hox genes in vertebrate development. Cell 78 (1994) 191-201
83. Lane T.F., Iruela-Arispe M.L., Johnson R.S., and Sage E.H. SPARC is a source of copper-binding peptides that stimulate osteogenesis. J. Cell Biol. 125 (1994) 929-943
84. Lazowski D.A., Fraher L.J., Hodsman A., Steer B., Modrowski D., and Han V.K. Regional variation of insulinlike growth hormone factor-I gene expression in mature rat bone and cartilage. Bone 15 (1994) 563-576
85. Leboy P.S., Beresford J.N., Devlin C., and Owen M.E. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol. 146 (1991) 370-378
86. Lee K., Deeds J.D., Chiba S., Un-No M., Bond A.T., and Segre G.V. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: In situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134 (1994) 441-450
87. Lee K., Deeds J.D., and Segre G.V. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 136 (1995) 453-463
88. Lian J.B., and Stein G.S. Transcriptional control of vitamin D-regulated proteins. J. Cell. Biochem. 49 (1992) 37-45
89. Lian J.B., Stein G.S., Bortell R., and Owen T.A. Phenotype suppression: A postulated molecular mechanism for mediating the relationship of proliferation and differentiation by fos/jun interactions at AP-1 sites in steroid responsive promoters elements of tissue-specific genes. J. Cell. Biochem. 45 (1991) 9-14
90. Liu F., Malaval L., Gupta A.K., and Aubin J.E. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: Polymerase chain reaction and immunocytochemical studies at the single cell level. Dev. Biol. 166 (1994) 220-234
91. Littlewood A.J., Aarden L.A., Evans D.B., Russell R.G.G., and Gowen M. Human osteoblastlike cells do not respond to interleukin-6. J. Bone Miner. Res. 6 (1991) 141-148
92. Lomri A., Marie P.J., Escurat M., and Portier M.M. Cytoskeletal protein synthesis and organization in cultured mouse osteoblastic cells: Effects of cell density. Febs Letters 222 (1987) 311-316
93. Lomri A., Marie P.J., Tran P.V., and Hott M. Characterization of endosteal osteoblastic cells isolated from mouse caudal vertebrae. Bone 9 (1988) 165-175
94. 2D in human osteoblastic cells. Bone and Mineral 10 (1990) 1-12
95. Lomri A., and Marie P.J. Distinct effects of calcium- and cAMP-enhancing factors on cytoskeletal assembly and synthesis in mouse osteoblastic cells. Biochim. Biophys. Acta 1052 (1990) 179-186
96. Lomri A., and Marie P.J. Effects of TGFβ on expression of cytoskeletal proteins in endosteal mouse osteoblastic cells. Bone 11 (1990) 445-451
97. Lomri A., and Marie P.J. Cytoskeleton in bone cell biology. In: Hesketh J.E., and Pyme I. (Eds). The Cyloskeleton (1996), JAI Press, Stamford, CT 229-264
98. Lomri A., de Pollak C., Goltzman D., Kremer R., and Marie P.J. Expression of PTHrP and PTH/PTHrP receptor in newborn human calvaria osteoblastic cells. Eur. J. Endocrinol. 136 8 (1997) 640-648
99. Lomri A., Lemonnier J., Hott M., de Perseval N., Lajeunie E., Munnich A., Renier D., and Marie P.J. Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor-2 mutations in Apert syndrome. J. Clin. Invest. 101 (1998) 1310-1317
100. Long M.W., Robinson L.A., Ashcraft E.A., and Mann K.G. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J. Clin. Invest. 95 (1995) 881-887
101. Lynch M.P., Stein J.L., Stein G.S., and Lian J.B. The influence of type-I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell Res. 216 (1995) 35-45
102. Lyons K.M., Pelton R.W., and Hogan B.L.M. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev. 3 (1989) 1657-1668
103. Lyons K.M., Michael Jones C., and Hogan B.L.M. The DVR gene family in embryonic development. Trends Gene 7 (1991) 408
104. Machwate M., Zerath E., Holy X., Hott M., Modrowski D., Malouvier A., and Marie P.J. Skeletal unloading in rat decreases proliferation of rat bone and marrow-derived osteoblastic cells. Am. J. Physiol. 264 (1993) E790-E799 Endocrinol. Metab. 27
105. Machwate M., Zerath E., Holy X., Pastoureau P., and Marie P.J. Insulinlike growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology 134 (1994) 1031-1038
106. Machwate M., Zerath E., Holy X., Hott M., Godet D., Lomri A., and Marie P.J. Systemic administration of transforming growth factor-β 2 prevents the impaired bone formation and osteopenia by unloading in rats. J. Clin. Invest. 96 (1995) 1245-1259
107. Machwate M., Jullienne A., Moukhtar M., Lomri A., and Marie P.J. c-fos proto-oncogene is involved in the mitogenic effect of transforming growth factor-β in osteoblastic cells. Molec. Endo. 9 (1995) 187-198
108. Machwate M., Jullienne A., Moukhtar M., and Marie P.J. Temporal variation of c-fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing bone. J. Cell. Biochem. 57 (1995) 62-70
109. Malaval L., Modrowski D., Gupta A., and Aubin J.E. Cellular expression of bone-related proteins in vitro osteogenesis in rat bone marrow stromal cell cultures. J. Cell. Physiol. 158 (1994) 555-572
110. Maniatopoulos C., Sodek J., and Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254 (1988) 317-330
111. Marcelli C., Yates A.J.P., and Mundy G.R. In vivo effects of human recombinant transforming growth factor-on bone turnoverin normal mice. J. Bone Miner. Res. 5 (1990) 1087-1096
112. Marie P.J., Sabbagh A., de Vernejoul M.C., and Lomri A. Osteocalcin and deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J. Clin. Endocrinol. Metab. 69 (1989) 272-279
113. Marie P.J., Hott M., and Perheentupa J. Effects of epidermal growth factor on bone formation and resorption in vivo. Am. J. Physiol. 258 (1989) E275-E281
114. Marie P.J., Lomri A., Sabbagh A., and Basle M. Culture and behavior of osteoblastic cells isolated from normal trabecular bone surfaces. In Vitro Cell. Biol. Dev. 25 (1989) 373-380
115. Marie P.J., de Vernejoul M.C., Connes D., and Hott M. Decreased DN A synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J. Clin. Invest. 88 (1991) 1167-1172
116. Marie P.J., de Vernejoul M.C., and Lomri A. Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. J. Bone Miner. Res. 7 (1992) 103-113
117. Marie P.J., Hott M., Launay J.M., Graulet A.M., and Gueris J. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women: Relationship with cell proliferation. J. Clin. Endocrinol. Metab. 77 (1993) 824-830
118. Marie P.J., and de Vernejoul M.C. Proliferation of bone surface-derived osteoblastic cells and control of bone formation. Bone 14 (1993) 463-468
119. Marie P.J., and de Vernejoul M.C. Local factors influencing bone remodeling. Rev. Rhum. 60 1 (1993) 55-63
120. Marie P.J., Hott M., and Lomri A. Regulation of endosteal bone formation and osteblasts in rodent vertebrae. Cells Mater. 4 (1994) 143-154
121. Marie P.J. Human osteoblastic cells: A potential tool to assess the etiology of pathologic bone formation. J. Bone Miner. Res. 9 (1994) 1847-1850
122. Marie P.J. Human osteoblastic cells: Relationship with bone formation. Calcif. Tissue Int. 56S (1995) 13-16
123. Marie P.J. Effects of bone morphogenetic proteins on cells of the osteoblastic lineage. J. Cell. Engin. 2 3 (1997) 92-99
124. Marie P.J. Growth factors and bone formation in osteoporosis: Roles for IGF-I and TGF-β. Rev. Rhum. 64 1 (1997) 44-53
125. Marie P.J., de Pollak C., Chanson P., and Lomri A. Increased osteoblastic cell proliferation associated with activating G, a mutation in monostotic and polyostotic fibrous dysplasia. Am. J. Pathol. 150 3 (1997) 1059-1069
126. Marie, P.J. (1998). Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histology and Histopathology (In press.).
127. Martin T.J., and Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J. Cell. Bioch. 56 (1994) 357-366
128. Martin T.J., Findlay D.M., Heath J.K., and Ng K.W. Osteoblasts: Differentiation and function. In: Mundy G.R., and Martin T.J. (Eds). Physiology and Pharmacology of Bone (1993), Springer-Verlag, New York 149-183
129. Mavilio F. Regulation of vertebrate homeobox-containing genes by morphogens. Eur. J. Biochem. 212 (1993) 273-288
130. Merriman H.L., LaTour D., Likhart T.A., Mohan S., Baylink D.J., and Strong D.D. Insulinlike growth factor-I and insulinlike growth factor-II induce c-fos in mouse osteoblastic cells. Calcif. Tissue Int. 46 (1990) 258-262
131. Modrowski D., Miravet L., Feuga M., Bannie F., and Marie P.J. Effect of fluoride on bone and bone cells in ovariectomized rats. J. Bone Miner. Res. 7 (1992) 961-969
132. Modrowski D., and Marie P.J. Cells isolated from the endosteal bone surface in adult rats express differentiated osteoblastic characteristics in vitro. Cell and tissue Res. 271 (1993) 499-505
133. Modrowski D., Miravet L., Feuga M., and Marie P.J. Increased proliferation of osteoblast precursor cells in estrogen-deficient rats. Am. J. Physiol. 264 (1993) E190-E196 Endocrinol. Metab. 27
134. Modrowski D., Godet D., and Marie P.J. Involvement of interleukin-1 and tumour necrosis factor a as endogenous growth factors in human osteoblastic cells. Cytokine 7 (1995) 7
135. Modrowski D., Lomri A., and Marie P.J. Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells. J. Cell. Physiol. 170 (1997) 35-46
136. Modrowski D., Lomri A., and Marie P.J. Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. J. Cell. Physiol. (1998) In press.).
137. Morgan B.A., and Tabin C.J. The role of homeobox genes in limb development. Curr. Opin. Genet. Dev. 3 (1993) 668-674
138. Mueller K., Cortesi R., Modrowski D., and Marie P.J. Stimulation of trabecular bone formation by insulinlike growth factor I in adult ovariectomized rats. Am. J. Physiol. 267 (1994) E1-E6 Endocrinol. Metab. 30
139. Mundy G.R. Local control of bone formation by osteoblasts. Clin. Orthop. Rel. Res. 313 (1995) 19-26
140. Nicolas V., Prewett A., Bettica P., Mohan S., Finkelman R.D., Baylink D.J., and Farley J.R. Age-related decreases in insulinlike growth factor-I and transforming growth factor-β in feromal cortical bone from both men and women: Implications for bone loss with aging. J. Clin. Endocrinol. Metab. 78 (1994) 1011-1016
141. Noda M., and Camilliere J.J. In vivo stimulation of bone formation by transforming growth factor. Endocrinology 124 (1989) 2991-2994
142. Ogata T., and Noda M. Expression of Id, a member of HLH protein family, is downregulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3EI. Biochem. Biophys. Res. Commun. 1991 (1991) 1194-1199
143. Owen M.E. Marrow stromal stem cells. J. Cell Sci. (Suppl. 10 (1988) 63-76
144. Owen T.A., Aronow M., Shalhoub V., Lian J.B., and Stein G.S. Progressive development of the rat osteoblast phenotype in vitro-reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol. 143 (1990) 420-430
145. Owen T.A., Bortell R., Yocum S.A., Smock S.L., Zhang M., Abate C., Shalhoub V., Aronin N., Wright K., Van Wijnen A.J., Stein J.L., Curran T., Lian J.B., and Stein G.S. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: Model for phenotype suppression of transcription. Proc Natl. Acad. Sci. USA 87 (1990) 9990-9994
146. Owen T.A., Aronow M., Barone L.M., Lian J.B., and Stein G.S. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype-dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128 (1991) 1496-1504
147. Parfitt A.M. Bone forming cells in clinical conditions. In: Hall B.K. (Ed). Bone, A Treatise, Vol. 1: The Osteoblast and Osteocyte (1990), The Telford Press, Caldwell, NJ. 351-429
148. Partanen J., Vainikka S., Korhonen J., Armstrong E., and Alitalo K. Diverse receptors for fibroblast growth factors. Progress Growth Factor Res. 4 (1992) 69-83
149. Partridge N.C., Bloch S.R., and Pearman A.T. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J. Cell. Biochem. 55 (1994) 321-327
150. Pfeilschifter J., Wolf O., Naumann A., and Mundy G.R. Chemotactic response of osteoblastlike cells to transforming growth factor β. J. Bone Miner. Res. 5 (1990) 825-830
151. Pfeilschifter J., Diel I., Pilz U., Brunotte K., Naumann A., and Ziegler R. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J. Bone Miner. Res. 8 (1993) 707-717
152. Puleo D.A., and Bizios R. RGDS tetrapeptide binds to osteoblasts and inhibits fibronectin-mediated adhesion. Bone 12 (1991) 271-276
153. Rapraeger A., Krufka A., and Olwin B.B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252 (1991) 1705-1708
154. Rawlinson S.C.F., El-Haj A.J., Minter S.L., Tavares I.A., Bennett A., and Lanyon L.E. Loading-related increases in prostaglandin production in cores of adult canine cancerous bone in vitro: A role for prostacyclin in adaptive bone remodeling? J. Bone Miner. Res. 6 (1991) 1345-1351
155. Rodan G.A., and Noda M. Gene expression in osteoblastic cells. Crit. Rev. Eukariotic Gene Expr. 1 (1991) 85-98
156. Rosen V., and Thies R.S. The BMP proteins in bone formation and repair. Trends Genet. 8 (1992) 97-102
157. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J.M., Maroteaux P., Le Merrer M., and Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371 (1994) 252-254
158. Ruoslahti E. Integrins. J. Clin. Invest. 87 (1991) 1-5
159. Ruther U., Garber C., Komitowski D., Müller R., and Wagner E.F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325 (1987) 412-416
160. Sandberg M.M., Aro H.T., and Vuorio E.I. Gene expression during bone repair. Clin. Orthop. 289 (1993) 292-312
161. Satokata I., and Maas R. Msx 1-deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nature Genet. 6 (1994) 348-356
162. Schipani E., Kruse K., and Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268 (1995) 98-100
163. Schmid C., and Ernst M. Insulinlike growth factors. In: Gowen M. (Ed). Cytokines and Bone Metabolism (1990), CRC Press, Ann Arbor, Michigan 229-265
164. Schulz A. "True bone" in vitro?. Virchow Archiv. 426 (1995) 103-105
165. a Hum. Mol. Gen. 4 (1995) 1675-1676
166. Shiang R., Thompson L.M., Zhu Y.Z., Church D.M., Fielder T.J., Bocian M., Winokur S.S.T., and Wasmuth J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
167. Shinar D.M., Endo N., Halperin D., Rodan G.A., and Weinreb M. Differential expression of insulinlike growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132 (1993) 1158-1167
168. Siddhanti S.R., and Quarles L.D. Molecular to pharmacologic control of osteoblast proliferation and differentiation. J. Cell. Biochem. 55 (1994) 310-320
169. Stein G.S., and Lian J.B. Molecular mechanisms mediating proliferation/ differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14 (1993) 424-442
170. Stein G.S., Lian J.B., Stein J.L., van Wijnen A.J., Frenkel B., and Montecino M. Mechanisms regulating osteoblast proliferation and differentiation. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, New York 69-86
171. Subramaniam M., Oursler M.J., Rasmussen K., Riggs B.L., and Spelsberg T.C. TGF-β regulation of nuclear proto-oncogenes and TGF-β gene expression in normal human osteoblastlike cells. J. Cell. Biochem. 57 (1995) 52-61
172. Suva L.J., Seedor J.G., Endo N., Quartuccio H.A., Thompson D.D., Bab I., and Rodan G.A. The pattern of gene expression following rat tibial marrow ablation. J. Bone Min. Res. 8 (1993) 379-388
173. Tamura M., and Noda M. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with Helix-Loop-Heltx- (HLH)-type transcription factors. J. Cell Biol. 126 (1994) 773-783
174. Turner R., and Spelsberg T. Correlation between mRN A levels for bone cell proteins and bone formation in long bones of maturing rats. Am. J. Physiol. 261 (1991) E348-E353 Endocrinol. Metab. 24
175. Towler D.A., Rutledge S.J., and Rodan G.A. Msx-2/Hox 8.1: A transcriptional regulatorof the rat osteocalcin promoter. Mol. Endocrin. 8 (1994) 1484-1493
176. Trémollières F.A., Strong D.D., Baylink D.J., and Mohan S. Progesterone and promegestone stimulate human bone cell proliferation and insulinlike growth factor-2 production. Acta Endocrin. 126 (1992) 329-337
177. Turksen K., and Aubin J.E. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell Biol. 114 (1991) 373-384
178. Turksen K., Bhargava H., Moe H., and Aubin J.E. Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo. J. Histochem. 40 (1992) 1339-1352
179. Vainio S., Karavanova I., Jowett A., and Thesleff I. Identification of BMP-4 a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 75 (1993) 45-58
180. Walsh C.A., Birch M.A., Fraser W.D., Robinson J., Lawton R., Dorgan J., Klenerman L., and Gallagher J.A. Primary cultures of human bone-derived cells produce parathyroid hormone-related peptide protein: A study of 40 patients of varying age and pathology. Bone Min 27 (1994) 43-50
181. Walsh S., Dodds R.A., James I.E., Bradbeer J.N., and Gowen M. Mononuclear antibodies with selective reactivity against osteoblasts and osteocytes in human bone. J. Bone Miner. Res. 9 (1994) 1687-1696
182. Wanaka A., Milbrandt J., and Johnson E. Expression of FGF receptor gene in rat development. Development 111 (1991) 455-468
183. Wang Z., Ovit Q.C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., and Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature (London 360 (1992) 741-745
184. Wilkie A.O.M., Morriss-Kay G.M., Jones E.Y., and Heath J.K. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5 (1995) 1-9
185. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32 (1992) 160-167
186. Yao K.L., Todescan R., and Sodek J. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J. Bone Miner. Res. 9 (1994) 231-240
187. Yotov W.V., Moreau A., and St-Arnaud R. The a-chain of the nascent polypeptide-associated complex functions as a transcriptional coactivator. Mol. Cell. Biol. 18 3 (1998) 1303-1311
188. Zhang R., Supowit S.C., Klein G.L., Lu Z., Christensen M., Lozano R., and Simmons D. Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cells. J. Bone Miner. Res. 10 (1995) 415-423